*Corresponding author:
Ahmed E Fazary, Chemistry Department, Faculty of Science, King Khalid University, Abha 9004, Kingdom of Saudi Arabia; Applied Research Sector, Egyptian Organization for Biological Products and Vaccines (VACSERA Holding Company), 51 Wezaret El-Zeraa St, Agouza, Giza, EgyptReceived: November 16, 2017; Published: November 29, 2017
DOI: 10.26717/BJSTR.2017.01.000546
To view the Full Article Peer-reviewed Article PDF
Recently drug discovery and development program based on the sustainable use of marine biodiversity have attracted much attention, because many scientists believe that its integration with recent advances in biotechnology not only promises economic benefits but also promotes the protection and conservation of marine biodiversity. Some biotechnological innovations have enabled to generate ecologically and environmentally sound approaches, which contribute greatly to the sustainable use of marine biodiversity. This emerging multidiscipline is especially interesting to be developed in Saudi Arabia as a wide country with highly diverse marine resources. Therefore here we will deal with developing a concept about how drug discovery based on marine natural products can be implemented to promote the sustainable use, protection and conservation of marine biodiversity as well as to secure economic benefits. Marine Organisms such as sponges and corals are broadly known as rich sources of novel and useful bioactive marine natural products as marine cancer drugs. However, it is not only elaborate pharmaceutically useful compounds but also produce a lot of toxic substances.